Characterization and Quality control of iPSC lines and myogenic derivatives. I

A report containing a molecular characterization (expression of pluripotency markers, embryoid bodies formation, karyotypic stability) of healthy, Cas9 inducible and patients with the 5 starting NMD iPSC. This report will also contain a detailed molecular characterization of their myogenic derivatives (banking reports, expression of myogenic markers, myoblast proliferation, myotubes terminal differentiation).